Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart

Investigative Radiology

Volumn 32, Issue 10, 1997, Pages 581-588

  Elst, Luce Vander ^a   Colet, Jean Marie ^a   Muller, Robert N ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

Contrast agents; Manganese; MnDPDP; P 31 nuclear magnetic resonance spectroscopy; Perfused rat heart

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; EDETIC ACID; MANGAFODIPIR; MANGANESE; MANGANESE CHLORIDE; NIFEDIPINE; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; HEART; HEART LEFT VENTRICLE PRESSURE; HEART RATE; INTERNALIZATION; MALE; METABOLISM; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

EID: 0031418346     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199710000-00001     Document Type: Article

References (18)

1. Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JKT, Noz ME. Hepatocellular tumors: Characterization with MnDPDP-enhanced MR imaging. Radiology 1993;188:53-59.
2. 2, Proceedings of the 2nd Meeting of the SMR 1994;2:297.
3. Brurok H, Schztt J, Berg K, Karlsson JOG, Jynge P. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate, and manganese chloride on cardiac function: An experimental study in the Langendorff perfused rat heart. Invest Radiol 1995;30:159-167.
4. Grant D, Zech K, Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest Radiol 1994;29:s249-s250.
5. White DL, Tongol JM, Roco CL, et al. Clearance, excretion, and organ distribution of Mn from the MRI contrast agent manganese dipyridoxal-diphosphate (Mn-DPDP). Proceedings of the 7th Meeting of the SMRM 1988;1:531.
6. Maton F, Van Haverbeke Y, Muller RN. A minimum protocol for characterization of paramagnetic contrast media. Proceedings of the 7th Meeting of the SMRM 1988;30.
7. Muller RN, Maton F, Van Haverbeke Y. Characterization of MRI contrast media by nuclear magnetic relaxation spectroscopy. Diagn Imag Int 1988;4:62-63.
8. 31P Studies. J Chem Phys 1965;43:3123-3132.
9. 31P Fourier-transform nuclear-magnetic resonance. Eur J Biochem 1973;38:54-58.
10. Langer GA, Serena SD, Nudd LM. Localization of contractile-dependent Ca: Comparison of Mn and verapamil in cardiac and skeletal muscle. Am J Physiol 1975;229:1003-1007.
11. 2+ on neonatal and adult rat heart: Initial depression and late augmentation of contractile force. Eur J Pharmacol 1992;222:223-226.
12. Hunter DR, Haworth RA, Berkoff HA. Cellular manganese uptake by the isolated perfused rat heart: A probe for the sarcolemma calcium channel. J Mol Cell Cardiol 1981;13:823-832.
13. 54Mn. Arch Biochem Biophys 1989;268:594-604.
14. Toft KG, Hustvedt SO, Grant D, et al. Metabolism and pharmacokinetics of mangafodipir trisodium (MnDPDP) in man. Acta Radiologica 1997;38:677-689.
15. Toft KG, Friisk GA, Skotland T. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: Detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography. J Pharmaceut Biomed Anal 1997;15:973-981.
16. Toft KG, Hustvedt SO, Martinsen I, Gordon PB. Metabolism, distribution and excretion of mangafodipir trisodium injection (MnDPDP) in healthy volunteers. MAGMA 1996:suppl 4(2):298.
17. Scholz TD. Reduction in myocardial high energy phosphate spin lattice relaxation times using manganese. NMR Biomed 1994:7: 137-140.
18. 2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart. Invest Radiol 1997;32:205-211.